MDXH MDxHealth SA - Ordinary Shares

NASDAQ · Biotechnology
$0.79
Price · Aug 19, 2026

MDXH Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.79
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$0 – $5

MDXH Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
MDXH
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
MDXH
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
MDXH
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
MDXH
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
MDXH
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
MDXH
Peer Median

MDXH Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 12 analysts
  • Strong Buy 3 25.0%
  • Buy 6 50.0%
  • Hold 3 25.0%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

5 analysts · 2026-08-19
Median target $2.00 +153.9%
Mean target $2.20 +179.3%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.03%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.18 $-0.20 0.02%
March 31, 2026 $-0.17 $-0.15 -0.01%
Dec. 31, 2025 $-0.17 $-0.13 -0.04%
Sept. 30, 2025 $-0.16 $-0.11 -0.05%
June 30, 2025 $-0.15 $-0.13 -0.02%
March 31, 2025 $-0.19 $-0.13 -0.06%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 29 filers · $6.3M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
5 (-5 vs prior Q) 31 (+19 vs prior Q) 6 (-5 vs prior Q) 4 (-13 vs prior Q) -131.8M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Bleichroeder LP $3,029,544 7,378,333 48.29% Shares
MVM Partners, LLC $1,911,206 4,700,457 30.46% Shares
PERKINS CAPITAL MANAGEMENT INC $579,722 1,411,891 9.24% Shares
RENAISSANCE TECHNOLOGIES LLC $133,479 325,084 2.13% Shares
JANE STREET GROUP, LLC $102,950 250,731 1.64% Shares
MILLENNIUM MANAGEMENT LLC $93,826 228,510 1.50% Shares
Toroso Investments, LLC $85,277 23,887 1.36% Shares
Squarepoint Ops LLC $82,235 200,281 1.31% Shares
XTX Topco Ltd $80,083 195,039 1.28% Shares
Cubist Systematic Strategies, LLC $53,122 11,424 0.85% Shares
Point72 Asia (Singapore) Pte. Ltd. $42,208 9,077 0.67% Shares
Ground Swell Capital, LLC $36,180 88,114 0.58% Shares
Tower Research Capital LLC (TRC) $15,007 36,549 0.24% Shares
FAS Wealth Partners, Inc. $9,290 22,625 0.15% Shares
Lido Advisors, LLC $8,316 20,253 0.13% Shares
Intesa Sanpaolo Wealth Management $4,106 10,000 0.07% Shares
CITADEL ADVISORS LLC $3,759 9,156 0.06% Shares
BlackRock, Inc. $2,790 6,794 0.04% Shares
GSA CAPITAL PARTNERS LLP $198 481,985 0.00% Shares
MORGAN STANLEY $168 410 0.00% Shares
WELLS FARGO & COMPANY/MN $82 200 0.00% Shares
HRT FINANCIAL LP $75 184,477 0.00% Shares
Virtu Financial LLC $55 134,178 0.00% Shares
Monetary Solutions, Ltd $35 85 0.00% Shares
SBI Securities Co., Ltd. $12 29 0.00% Shares
BARCLAYS PLC $7 16 0.00% Shares
Cambridge Investment Research Advisors, Inc. $4 10,000 0.00% Shares
Farther Finance Advisors, LLC $4 10 0.00% Shares
UBS Group AG $1 3 0.00% Shares

Company insiders 10 insiders · 0 officers · 0 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
MVM Partners, LLC 10% owner Feb. 3, 2023 P 45,504,584 0 0 $0
Brendan Oconnell June 1, 2026 A 0 0 $0
Joseph Sollee June 1, 2026 A 0 0 $0
Sanford Jay Siegel June 1, 2026 A 0 0 $0
Koen Hoffman June 1, 2026 A 0 0 $0
Hilde Windels June 1, 2026 A 0 0 $0
Michael Holder June 1, 2026 A 0 0 $0
Michael Mcgarrity June 1, 2026 A 0 0 $0
John Bellano June 1, 2026 A 0 0 $0
Don M Hardison June 1, 2026 A 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 4 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Bleichroeder LP, Bleichroeder Holdings LLC, Andrew Gundlach Aug. 14, 2026 33.20% Initial filing Passive investment SEC
MVM Partners, LLC, MVM V LP, MVM GP (No.5) LP ×3 filings Oct. 28, 2024 Initial filing SEC
Valiance Asset Management Limited, TopMDx Ltd., Valiance Life Sciences Growth Investments GP S.à r.l., Valiance Life Sciences Growth Investments SICAV-SIF ×2 filings April 14, 2023 Initial filing SEC
MVM Partners LLP, MVM V LP, MVM GP (No.5) LP Dec. 27, 2021 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 1 ETF

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.00% 140,269 SH Aug. 8, 2026 Daily